1 Min Read
Oct 7 (Reuters) - Biocartis Group NV :
* Three Idylla test performance studies to be presented at ESMO oncology conference Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.